Prescription Drug Monitoring Program (PDMP)

Similar documents
Prescription Drug Monitoring Program (PDMP)

Prescription Drug Monitoring Program (PDMP)

Prescription Drug Monitoring Program (PDMP) LOUISIANA. Information contained in this presentation is accurate as of September 2017

District of Columbia Prescription Drug Monitoring Program

How to Get the Most Out of Prescription Drug Monitoring Programs

Nevada. Contact Information. State Registrant Totals and Population

New Mexico. Contact Information. State Registrant Totals and Population. PDMP name: NM PMP

STATE OF TEXAS TEXAS STATE BOARD OF PHARMACY

Ohio. Contact Information. State Registrant Totals and Population

Michigan. Contact Information. State Registrant Totals and Population. PDMP name: MAPS

Tennessee. Tennessee Department of Health, Tennessee Board of Pharmacy Pharmacy Board

Pharmacy Law Update for Pharmacists & Technicians October 1, 2017 Greg Baran, B.S., Pharm., M.A.

North Carolina. Contact Information. State Registrant Totals and Population. PDMP region: PDMP name: Agency responsible:

Kentucky. Kentucky Cabinet for Health and Family Services Office of Inspector General

Massachusetts. Contact Information. State Registrant Totals and Population. PDMP name: MA Prescription Monitoring Program

Reporting Requirements and Exemptions to Reporting

Tennessee. Contact Information. State Registrant Totals and Population. PDMP name: CSMD

Mississippi. Contact Information. State Registrant Totals and Population

Alaska. Contact Information. State Registrant Totals and Population. PDMP name: AKPDMP

Evidence-Based Practices to Optimize Prescriber Use of PDMPs

K-TRACS: Review of Program Data and a Qualitative Assessment Study

Oklahoma. Contact Information. Office: Fax: Statistics

Colorado. Contact Information

Prescription Monitoring Program State Profiles - California

Technical Assistance Guide. Enhancing PDMPs: A Comparison of Changes 2010 to 2016

PRESCRIPTION MONITORING PROGRAM STATE PROFILES TENNESSEE

Prescription Monitoring Program State Profiles - Illinois

Puerto Rico. Contact Information. State Registrant Totals and Population. PDMP name: PR PDMP

States that Allow Prescribers and/or Dispensers to Appoint a Delegate to Access the PMP

Georgia DPH. Prescription Title Drug Heading Monitoring Program Program. Sheila Pierce April 2018

Prescription Monitoring Programs - Legislative Trends and Model Law Revision

Prescription Monitoring Program State Profiles - Michigan

The Wisconsin epdmp:

STATE STATUTORY AND REGULATORY LIMITS: DIRECT DISPENSING OF CONTROLLED SUBSTANCES BY PRACTITIONERS TO ULTIMATE USERS

Steps Taken to Combat the Opiate Epidemic Through Legal And Technological Channels. Nick Snyder, Esq.

Prescription Monitoring Program:

NATIONAL ASSOCIATION FOR STATE CONTROLLED SUBSTANCES AUTHORITIES (NASCSA) MODEL PRESCRIPTION MONITORING PROGRAM (PMP) ACT (2016) COMMENT

Summer Webinar Series. The Prescription Drug Monitoring Program (PDMP) Mandate and Where you Fit In June 21, 2018

OREGON HEALTH AUTHORITY, DIVISION OF MEDICAL ASSISTANCE PROGRAMS

Prescription Monitoring Program State Profiles - Texas

Delegator Dashboard User Guide

(b) Is administered via a transdermal route; or

DC Board of Pharmacy and Pharmaceutical Control Update

Legal Issues in Managing Opioid Abuse. Gwen Dayton, JD

Technical Assistance Guide. Prescriber Report Cards

10/4/12. Controlled Substances Dispensing Issues and Solutions. Objectives. Financial Disclosure

AN ACT. Be it enacted by the General Assembly of the State of Ohio:

GENERAL ASSEMBLY OF NORTH CAROLINA SESSION 2017 S 2 SENATE BILL 750* Health Care Committee Substitute Adopted 6/12/18

Annual Report to the Prescription Drug Monitoring Program Advisory Commission

States that Allow Prescribers and/or Dispensers to Appoint a Delegate to Access the PMP

Massachusetts Prescription Monitoring Program

PRESCRIBING IN NEVADA

Advancing MN Pharmacy 2016 Advocacy Accomplishments & 2017 Plans

National Association of Boards of Pharmacy PMP Interconnect NABP

Medication Assisted Treatment for Opioid Use Disorders Reporting Requirements

SENATE, No STATE OF NEW JERSEY. 216th LEGISLATURE INTRODUCED APRIL 28, 2014

Florida s New Law on Controlled Substance Prescribing

2017 ASAP MIDYEAR CONFERENCE THE FUTURE OF PRESCRIPTION DRUG MONITORING PROGRAMS (PMPS): HIGHLIGHTS OF 2017 STATE BILLS JUNE 22, 2017 SHERRY L.

Mid-Atlantic Legislative/Regulatory June 2018 Update

Prescriber Use of the PDMP: A Statewide Survey and Multistate Focus Groups

Findings and Recommendations of the Prescription Monitoring Standards Workgroup

Hydrocodone Prescribing and the New Texas PMP

Trends In APRN Practice Authority

Understanding the Pharmacy and Drug Act amendments and mail order pharmacy licensing

EPCS FREQUENTLY ASKED QUESTIONS FOR ELECTRONIC PRESCRIBING OF CONTROLLED SUBSTANCES. Revised: March 2016

RULES OF THE TENNESSEE BOARD OF NURSING CHAPTER ADVANCED PRACTICE NURSES & CERTIFICATES OF FITNESS TO PRESCRIBE TABLE OF CONTENTS

TITLE 5 LEGISLATIVE RULE WEST VIRGINIA BOARD OF DENTISTRY SERIES 11 CONTINUING EDUCATION REQUIREMENTS

Interim Commissioner Lauren A. Smith and Members of the Public Health Council

NATIONAL PROGRESS REPORT

South Carolina Reporting & Identification Prescription Tracking System (SCRIPTS)

a remote pharmacy is not necessarily intended to provide permanent??? how do we make it so that it may be only for limited duration.

NEW MEXICO PRACTITIONER S MANUAL

NCPDP s Recommendations for an Integrated, Interoperable Solution to Ensure Patient Safe Use of Controlled Substances

SUBCHAPTER 32M - APPROVAL OF NURSE PRACTITIONERS

CHAPTER 29 PHARMACY TECHNICIANS

Mandatory Electronic Prescribing in NYS

INCREASE ACCESS TO PRIMARY CARE SERVICES BY ALLOWING ADVANCED PRACTICE REGISTERED NURSES TO PRESCRIBE

Prescription Monitoring Program State Profiles - Pennsylvania

South Carolina Compliance Update

The Challenges of Interstate Data Sharing

REGULATION MARKUP REGULATION NO. 2

Fall Provider Workshops 2017

Types of Authorized Recipients Probation/Parole Officers or the Department of Corrections

NCPDP Work Group 11 Task Group: RxFill White Paper on Implementation Issues

As Introduced. 131st General Assembly Regular Session H. B. No

RULES OF TENNESSEE DEPARTMENT OF LABOR AND WORKFORCE DEVELOPMENT WORKERS COMPENSATION DIVISION

BJA COAP Category 5 Grantee Webinar Thursday, June 21, 2018

GENERAL ASSEMBLY OF NORTH CAROLINA SESSION 2017 SESSION LAW SENATE BILL 750

Prescription Drug Monitoring Programs: Promising Practices to Maximize Their Effectiveness

Improving Care for Dual Eligibles through Health IT

Licensed Pharmacy Technicians Scope of Practice

247 CMR: BOARD OF REGISTRATION IN PHARMACY

AN ACT. Be it enacted by the General Assembly of the State of Ohio:

Bold blue=new language Red strikethrough=deleted language Regular text=existing language Bold Green = new changes following public hearing

-Health Update. Encounter Notification System (ENS) Celebrates Five Years! Welcome

Please adjust your computer volume to a comfortable listening level. This is lesson 4 How do you handle medication at home?

PMIX ADVANCING PMP DATA SHARING THROUGH STANDARDIZATION AND INNOVATION CARL FLANSBAUM, DIRECTOR, NEW MEXICO PMP CO-CHAIR PMIX WORKING GROUP

Interstate Pay Differential

(7) Indicate the appropriate and explicit directions for use. (9) Not authorize any refills for schedule II controlled substances.

CHAPTER 15 F425 - PHARMACY SERVICES THE MEDICATION AUDIT TRAIL (ORDERING, RECEIVING AND DISPOSITION OF MEDICATION) 15.1

Transcription:

Prescription Drug Monitoring Program (PDMP) West Virginia Information contained in this presentation is accurate as of October 2017

What is a Prescription Drug Monitoring Program? A PDMP/PMP is a statewide electronic database which collects designated data on specified substances dispensed to or for patients. The PDMP is housed by a state regulatory, administrative or law enforcement agency. The housing agency disseminates information from the database to individuals who are authorized under state law to receive the information for purposes identified by state law. 2

Meet the Speaker Jerad Bailey 3

State PDMP Overview RxDataTrack CSAPP (Controlled Substance Automated Prescription Program) The data is housed in a high security, HIPAAcompliant database within the state of West Virginia. CSAPP since 2013 Internet-based CSMP since 2004 4

State PDMP Overview All licensees who dispense Schedule II, III and IV controlled substances to residents of West Virginia must provide the dispensing information to the West Virginia Board of Pharmacy (BOP) each 24 hour period basis. Also includes Schedule V controlled substances (eg. pseudoephedrine) dispensed as a prescription Gabapentin-containing products Naloxone-containing opioid-reversing agents (eg. Narcan ) 5

Exceptions/Exclusions for Reporting WV Code 60A-9-3(c)(2) A dispenser, who does not have an automated record-keeping system capable of producing an electronic report in the established format may request a waiver from electronic reporting. The request for a waiver [ ] shall be granted if the dispenser agrees in writing to report the data by submitting a completed "Pharmacy Universal Claim Form" as defined by legislative rule. WV Code 60A-9-4(d) Reporting required by this section is not required for a drug administered directly to a patient by a practitioner. Reporting is, however, required by this section for a drug dispensed to a patient by a practitioner: Provided, That the quantity dispensed [ ] may not exceed [a seventy-two-hour supply] with no greater than two seventy-two-hour cycles dispensed in any fifteen-day period of time. 6

Data Exchange Time Period WV Code 60A-9-3(b) The information required to be submitted by the provisions of this article shall be required to be filed no more frequently than within twenty-four hours. WV Code 60A-9-4(a)(1) through (9) (1) Dispensing pharmacy/provider s name, address, Rx#, and DEA# (2) Full legal name, address, DOB of patient (3) Name, address, and DEA# of prescriber (4-5) Name, NDC, and quantity of medication dispensed (6) Date prescription was written/filled (7) Number of refills authorized by prescriber (8) Full name, address, and DOB listed on government-issued photo ID of person picking up medication (9) Source of payment (eg. Cash, Medicaid, Third Party) 7

Data Exchange Time Period Database refreshes are constant Pharmacy will receive a report next-day that their data has been submitted, and any errors which may need corrected Reporting is near-instantaneous Receiving a report is quick; logging in and typing the necessary information is the slow part 8

Approved Users Access is granted to Physicians, Pharmacists, Dentists, Veterinarians, Physician Assistants, Advanced Practice Nurses, and Other Prescribers and Dispensers Authorized agents of select law-enforcement agencies (drug task forces, DEA, Bureau of Medical Services), Office of Chief Medical Examiner, and Licensing Boards WV Code 60A-9-5 Entitled Confidentiality; limited access to records; period of retention; no civil liability for required reporting For medical practitioners, access should be pursuant to the actual care of patients 9

Mandates WV Code 60A-9-5a (a) All practitioners [ ] who prescribe or dispense Schedule II, III or IV controlled substances shall register with the West Virginia Controlled Substances Monitoring Program [and maintain access]: Provided, That compliance [ ] must be accomplished within thirty days of the practitioner obtaining a new license. [ ] (b) Upon initially prescribing or dispensing any pain-relieving controlled substance for a patient and at least annually thereafter should the practitioner or dispenser continue to treat the patient with controlled substances, all persons with prescriptive or dispensing authority [ ] shall access the West Virginia Controlled Substances Monitoring Program database for information regarding specific patients for whom they are providing pain-relieving controlled substances as part of a course of treatment for chronic, nonmalignant pain but who are not suffering from a terminal illness. The information obtained from accessing the West Virginia Controlled Substances Monitoring Program database for the patient shall be documented in the patient's medical record. [ ] 10

Limitations of Matching Data Name mismatches Shortened names (eg. John vs. Jonathan) Married names (Smith, Jones, Smith-Jones, Jones-Smith) Broaden search by using less info Can run a report with as little as patient s last name Output report will have patient s first name, DOB, and other relevant information Use the information on the patient s photo ID Best practice 11

Data Availability Data is accessed online via RxDataTrack CSAPP Each DEA Registrant (Provider, Pharmacy, etc.) has its own account Individuals can create a delegate account and upon approval be associated with one or more DEAs Board of Pharmacy Monitoring Letters sent to providers and dispensers about patients exceeding established parameters Patients highest on list were referred to law enforcement Substance Abuse and Mental Health Services (SAMSHA) Grant CSMP integration into workflows 12

Other State Databases As of February 2016 Interconnectivity with Arizona, Connecticut, Indiana, Kansas, Kentucky, Maryland, Nevada, New Mexico, Ohio, Virginia Pennsylvania absent from this list Interstate data only available to practitioners at this time Most states limit delegate access to CSMP Limits interstate data exchange 13

Analytics Available to Pharmacies Morphine Milligram Equivalents (MME) Available to Practitioners Dispensing self-reports Top prescriber reports Available to Board of Pharmacy Multiple prescriber Prescribers with no access to CSMP User activity 14

Trends and Use Patterns Reports and analytics available to the Board of Pharmacy Top products dispensed Patient demographics (age, city/county) Distance traveled between prescriber and pharmacy % of prescriptions being paid for with cash Advisory and Database Review Committees Inform physicians and pharmacies of anomalies and patient deaths 15

State PDMP Moving Forward Veterans Administration Ability to receive dispensing data SAMSHA Grant Workflow integration New CSMP Vendor Possibility for a new system entirely 16

Thank you for watching! For more information about West Virginia s Prescription Drug Monitoring Program, please contact: Michael Goff (Administrator) michael.l.goff@wv.gov (304) 558-0558 Cindy Parsons (Senior Analyst) cynthia.y.parsons@wv.gov (304) 558-0558 17